睿智医药两股东拟减持合计不超6%股份

Core Viewpoint - The major shareholders of Ruizhi Pharmaceutical (300149.SZ) plan to reduce their holdings by a total of 14.9389 million shares, representing 3% of the company's total share capital, within three months after a 15-trading-day notice period [1] Group 1: Shareholder Actions - Shareholder Liang Yufeng intends to reduce her stake by up to 14.9389 million shares, which is 3% of the total share capital, through centralized bidding or block trading within three months after the notice period [1] - Shareholder Yu Xianwen also plans to reduce his holdings by the same amount of 14.9389 million shares, accounting for 3% of the total share capital, using similar methods within the specified timeframe [1]